A prospective randomised controlled trial comparing the use of open label pentoxifylline and tocopherol versus current standard of care for the prevention of fibrosis related outcomes in irradiated head and neck oncology patients (Feasibility Study)
Latest Information Update: 09 Oct 2023
At a glance
- Drugs Pentoxifylline (Primary) ; Tocopherol
- Indications Deglutition disorders; Fibrosis; Osteoradionecrosis
- Focus Adverse reactions
- Acronyms PenVe
Most Recent Events
- 11 Oct 2022 Status changed from recruiting to completed.
- 11 Oct 2022 Planned End Date changed from 1 Oct 2022 to 30 Sep 2023.
- 11 Oct 2022 The recruitment end date has been changed from 30/06/2022 to 13/07/2022.